Bronatisha developed a severe facial enlargement caused by a complex vascular malformation. In late 2024 she was referred to CTC Inc., and with PMGH and CFF we coordinated her referral to Australia.
Detailed investigations in Melbourne showed the malformation was more complex than expected, making immediate surgery too risky. Her specialist recommended medication that may reduce its size over three to six months before reassessment.
Her journey is not yet complete — but with continued support, hope remains alive.
